Adicet Bio, Inc. announced that it will receive $80,000,000 in funding on July 25, 2019. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,660 KRW | +1.10% | -0.81% | +16.56% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
13,830 KRW | -.--% | +3.67% | 138M | ||
903.5 USD | +1.44% | -0.34% | 96.09B | ||
1.52 USD | +2.01% | -18.93% | 122M | ||
1st Jan change | Capi. | |
---|---|---|
+16.56% | 70.03M | |
+31.41% | 12.02B | |
+15.78% | 3.06B | |
-8.46% | 1.23B | |
+1.77% | 658M | |
+45.05% | 617M | |
+0.71% | 615M | |
-4.17% | 495M | |
+30.43% | 473M | |
+3.90% | 306M |
- Stock Market
- Equities
- A241520 Stock
- News DSC Investment Inc.
- Adicet Bio, Inc. announced that it expects to receive $80 million in funding